|
Updated: 12/12/06 08:23 AM |
|
 |
| HOME | HEAL | EDUCATE | RESEARCH | DIRECTORY | OUTREACH |
The goal for management of these patients is to diagnose them prior to the development of cancer, when they have precancer or dysplasia, and to perform a complete pancreatectomy. Timing is of vital importance for determining when a patient warrants surgery; if the patient is diagnosed too late, he or she dies of pancreatic cancer. It is vital to know the histologic diagnosis of the patient before considering major surgical options. High risk patients who have an abnormal endoscopic ultrasound and abnormal pancreatic ducts on ERCP, may warrant a tissue diagnosis to confirm that precancerous changes are present in the pancreas. This can be done by using a laparoscope to obtain a sample of the pancreas for histologic evaluation. If carcinoma-in-situ is present (also called PanIN III or high grade dysplasia) a consideration for total pancreatectomy is discussed with the patient. If performed too early, the patient is put through a major operation and he or she will be diabetic. At the operation, the entire pancreas is removed because the precancerous changes can involve the whole organ--any pancreas that is left behind can potentially develop cancer.
Familial Pancreatic Cancer » |
Who is at Risk? » |
History & Physical Examination »
Family History » | Surveillance » | Outcome »
Family History » | Surveillance » | Outcome »